Kids & teens (for parents) · Illinois
Studies for children and teens in Illinois
These studies only enroll people under 18. A parent or legal guardian gives permission, and children old enough to understand are asked for their own agreement (assent).
75 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 4
Rifaximin 200 mg Plus Oral Rehydration vs Oral Rehydration Alone in Children With Acute Diarrhea
Bausch Health Americas, Inc.
- Location
- Island Lake, IL + 9 other US sites
- Eligibility basics
- Ages 6–12
- RecruitingPhase 2
Posaconazole (MK-5592) Intravenous and Oral in Children (<2 Years) With Invasive Fungal Infection (MK-5592-127)
Merck Sharp & Dohme LLC
- Location
- Chicago, IL
- Eligibility basics
- Ages 0 mo–2
- RecruitingPhase 3
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Eli Lilly and Company
- Location
- Chicago, IL + 39 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
AbbVie
- Location
- Orland Park, IL + 30 other US sites
- Eligibility basics
- Ages 10–17
- RecruitingPhase 2
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
Pfizer
- Location
- Chicago, IL + 11 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 1/Phase 2
A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE)
Solid Biosciences Inc.
- Location
- Chicago, IL + 11 other US sites
- Eligibility basics
- Ages 0 mo–17 · Men only
- RecruitingPhase 3
Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia
Vanda Pharmaceuticals
- Location
- Naperville, IL + 18 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic…
Takeda
- Location
- Chicago, IL + 7 other US sites
- Eligibility basics
- Up to age 17
- RecruitingPhase 3
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
Takeda
- Location
- Park Ridge, IL + 7 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 2
A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Patients Aged 8 to 17 With Complicated Intra-abdominal Infections (cIAI)
Tetraphase Pharmaceuticals, Inc
- Location
- Chicago, IL + 4 other US sites
- Eligibility basics
- Ages 8–17
- RecruitingPhase 1/Phase 2
A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)
Aspa Therapeutics
- Location
- Chicago, IL + 2 other US sites
- Eligibility basics
- Up to age 2
- RecruitingPhase 1/Phase 2
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)
Noveome Biotherapeutics, formerly Stemnion
- Location
- Evanston, IL + 7 other US sites
- Eligibility basics
- Ages 0 mo–2 mo
- RecruitingPhase 2
A Study of Vosoritide Versus Placebo in Children With Hypochondroplasia Aged 0 to < 36 Months
BioMarin Pharmaceutical
- Location
- Chicago, IL + 6 other US sites
- Eligibility basics
- Ages 0 mo–3
- RecruitingPhase 2
Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome
RECORDATI GROUP
- Location
- Chicago, IL + 3 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Halozyme Therapeutics
- Location
- Chicago, IL + 19 other US sites
- Eligibility basics
- Ages 12–17 · Men only
- RecruitingPhase 3
Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
Sun Pharmaceutical Industries, Inc.
- Location
- Chicago, IL + 53 other US sites
- Eligibility basics
- Ages 12–17
- RecruitingPhase 3
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
Pfizer
- Location
- Chicago, IL + 4 other US sites
- Eligibility basics
- Ages 0 mo–17
- Recruiting
Hyrax Vs. Invisalign Palatal Expander Clinical Study
Align Technology, Inc.
- Location
- Naperville, IL + 3 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingHealthy volunteers
Study of Mental Health and Relationships
University of Illinois at Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 9–16
- RecruitingHealthy volunteersPhase 3
Delaying the Onset of Nearsightedness Until Treatment (DONUT) Clinical Trial
Ohio State University
- Location
- Chicago, IL + 11 other US sites
- Eligibility basics
- Ages 6–11
- RecruitingHealthy volunteers
Patient Navigators for Children's Community Mental Health Services in High Poverty Urban Communities
University of Illinois at Chicago
- Location
- Chicago, IL
- Eligibility basics
- Up to age 14
- RecruitingHealthy volunteers
Protocol CAUSE-03 / CHEETAH
National Institute of Allergy and Infectious Diseases (NIAID)
- Location
- Chicago, IL + 7 other US sites
- Eligibility basics
- Ages 6–17
- RecruitingHealthy volunteersPhase 2
Soy Isoflavones For Inner City Infants At Risk For Asthma (SIRA) Study
Rajesh Kumar
- Location
- Chicago, IL + 1 other US site
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteers
A Randomized Controlled Trial Testing the Effect of the Youth Mindful Awareness Program on Negative Affect (YMAP2).
Vanderbilt University
- Location
- Evanston, IL + 2 other US sites
- Eligibility basics
- Ages 12–17